Department of Medicine

Medicine & Life Sciences

1. Heterochromatin 100%
2. Kazakhstan 82%
3. heterochromatin-specific nonhistone chromosomal protein HP-1 80%
4. Chromatin 46%
5. Histones 43%
6. T-Lymphocytes 40%
7. Proteins 40%
8. HIV 37%
9. Autoimmune Hepatitis 31%
10. Antigens 28%
11. Therapeutics 28%
12. Serum 27%
13. Epigenomics 27%
14. Lysine 27%
15. Hepacivirus 26%
16. Prostatic Neoplasms 25%
17. Virus Diseases 25%
18. Urine 25%
19. Kuwait 23%
20. Kidney 23%
21. Genes 22%
22. Child 21%
23. Liver 21%
24. Prostate-Specific Antigen 21%
25. Chronic Hepatitis 20%
26. Survivin 20%
27. Testis 20%
28. Armenia 20%
29. Neoplasms 19%
30. Drosophila 19%
31. Infections 19%
32. Hepatitis B virus 18%
33. Population 18%
34. Pediatrics 18%
35. Drosophila heterochromatin protein 1 18%
36. Spermatic Cord Torsion 18%
37. Infertility 18%
38. Mortality 18%
39. Histone Code 18%
40. Hepatitis B Surface Antigens 18%
41. Nuclear Envelope 18%
42. Hepatitis B 17%
43. Methylation 17%
44. Celiac Disease 17%
45. Hepatitis C 17%
46. Prostate 17%
47. Alleles 16%
48. Rabbits 16%
49. Chromosomal Position Effects 16%
50. Endometriosis 16%
51. nuclear matrix protein 22 16%
52. Hepatitis 16%
53. Epitopes 16%
54. Central Asia 15%
55. Antibodies 15%
56. Viruses 15%
57. HIV-1 15%
58. HLA-DQB1 antigen 15%
59. Cellular Immunity 15%
60. Chromosomes 15%
61. Peptides 14%
62. Cytokines 14%
63. Pharmaceutical Preparations 14%
64. Massive Hepatic Necrosis 14%
65. Biopsy 14%
66. Asialoglycoprotein Receptor 14%
67. Bone Fractures 13%
68. Spermatogenesis 13%
69. In Vitro Techniques 13%
70. Autoantibodies 13%
71. Phenotype 13%
72. Liver Diseases 12%
73. Euchromatin 12%
74. Incidence 12%
75. Transplant Recipients 12%
76. Stents 12%
77. Antiviral Agents 12%
78. Prostatic Hyperplasia 12%
79. Urography 12%
80. Pregnancy 12%
81. Urinary Bladder Neoplasms 12%
82. Calculi 11%
83. Uterine Cervical Neoplasms 11%
84. Hepatitis A virus 11%
85. Lithotripsy 11%
86. Centromere 11%
87. Anti-Bacterial Agents 11%
88. Gene Silencing 11%
89. Chronic Hepatitis B 11%
90. Delivery of Health Care 11%
91. Guidelines 11%
92. Cost-Benefit Analysis 10%
93. Pain 10%
94. Urinary Bladder 10%
95. Genetic Predisposition to Disease 10%
96. Pandemics 10%
97. HIV Infections 10%
98. Prospective Studies 10%
99. Hormones 10%